SARS-CoV-2 Spike protein promotes hyper-inflammatory response that can be ameliorated by Spike-antagonistic peptide and FDA-approved ER stress and MAP kinase inhibitors in vitro
暂无分享,去创建一个
P. Pathinayake | P. Wark | P. Hansbro | A. Reid | Fang Wang | J. Horvat | A. Hsu | P. Veerati | Guoqiang Wang | Katie Daly | Jemma R. Mayall | J. Mayall | Andrew T Reid | K. Daly